I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Tougeron, D
870
results:
english X
Search for persons
X
Format
Online (870)
Mediatypes
Articles (Online) (228)
OpenAccess-fulltext (642)
Sorted by: Relevance
Sorted by: Year
?
1
47P Does metastatic site influence the outcome in colorecta..:
Smolenschi, C.
;
Tanguy, M-L.
;
Ben Abdelghani, M.
...
Annals of Oncology. 35 (2024) - p. S23 , 2024
Link:
https://doi.org/10.1016/..
?
2
395MO Tislelizumab (TIS) + chemotherapy (CT) vs placebo (PB..:
Raymond, E.
;
Xu, J.
;
Kato, K.
...
Annals of Oncology. 35 (2024) - p. S159 , 2024
Link:
https://doi.org/10.1016/..
?
3
3O PRODIGE 68 - UCGI 38 - SOREGATT: A randomized phase II s..:
Ducreux, M.P.
;
Ben Abdelghani, M.
;
Tougeron, D.
...
Annals of Oncology. 35 (2024) - p. S3 , 2024
Link:
https://doi.org/10.1016/..
?
4
LBA1 Pembrolizumab in combination with xelox and bevacizuma..:
Tougeron, D.
;
Emile, J.F.
;
Bodere, A.
...
Annals of Oncology. 35 (2024) - p. S212 , 2024
Link:
https://doi.org/10.1016/..
?
5
496TiP Randomised phase II study evaluating trifluridine/ti..:
de la Fouchardiere, C.
;
Chabaud, S.
;
Perrier, H.
...
Annals of Oncology. 35 (2024) - p. S197-S198 , 2024
Link:
https://doi.org/10.1016/..
?
6
31P Effect of fruquintinib in patients with heavily pretrea..:
Tabernero, J.
;
Eng, C.
;
Lonardi, S.
...
Annals of Oncology. 35 (2024) - p. S15-S16 , 2024
Link:
https://doi.org/10.1016/..
?
7
66P Targeted treatment (TT) after immune checkpoint inhibit..:
Ambrosini, M.
;
Tougeron, D.
;
Modest, D.P.
...
Annals of Oncology. 35 (2024) - p. S32 , 2024
Link:
https://doi.org/10.1016/..
?
8
Prediction of response to immune checkpoint blockade in pat..:
Ratovomanana, T.
;
Nicolle, R.
;
Cohen, R.
...
Annals of Oncology. 34 (2023) 8 - p. 703-713 , 2023
Link:
https://doi.org/10.1016/..
?
9
OC-0277 Capecitabine or 5-fluorouracil infusion with radiot..:
Delhiat, A.
;
Lemanski, C.
;
Le-Malicot, K.
...
Radiotherapy and Oncology. 182 (2023) - p. S211-S212 , 2023
Link:
https://doi.org/10.1016/..
?
10
139P Genomic prognostic and potential theragnostic factors ..:
Hamza, A.
;
Masliah-Planchon, J.
;
Neuzillet, C.
...
ESMO Open. 8 (2023) 1 - p. 101989 , 2023
Link:
https://doi.org/10.1016/..
?
11
Long term activity of vemurafenib in cancers with BRAF muta..:
Blay, J.Y.
;
Cropet, C.
;
Mansard, S.
...
ESMO Open. 8 (2023) 6 - p. 102038 , 2023
Link:
https://doi.org/10.1016/..
?
12
CO170 Treatment Exposure-Adjusted Event Rates (EAERs) for G..:
Howe, A.
;
Hernandez, L.G.
;
Paly, V.
...
Value in Health. 26 (2023) 12 - p. S44-S45 , 2023
Link:
https://doi.org/10.1016/..
?
13
Esophageal cancer - French intergroup clinical practice gui..:
Veziant, Julie
;
Bouché, Olivier
;
Aparicio, T.
...
Digestive and Liver Disease. 55 (2023) 12 - p. 1583-1601 , 2023
Link:
https://doi.org/10.1016/..
?
14
Efficacy of immunotherapy in mismatch repair-deficient adva..:
Alouani, E.
;
Mercier, M.
;
Flecchia, C.
...
ESMO Open. 8 (2023) 3 - p. 101574 , 2023
Link:
https://doi.org/10.1016/..
?
15
EE416 Cost-Effectiveness of Pembrolizumab Monotherapy for F..:
Aguiar-Ibáñez, R
;
Cagnan, L
;
Bensimon, L
...
Value in Health. 25 (2022) 12 - p. S137 , 2022
Link:
https://doi.org/10.1016/..
1-15